-

QST Consultations, Ltd. Announces Name Change to Abond CRO Inc. and New Brand To Support Expanded Capabilities and Partnership Approach

ALLENDALE, Mich.--(BUSINESS WIRE)--QST Consultations, Ltd. changed its name to Abond CRO Inc., launching the new brand via their website and participation at S.C.O.P.E., February 18-21 in Orlando, FL.

Since its founding in 1974 by John Quiring, PhD, QST Consultations has built long-standing partnerships with pharmaceutical and medical device companies by providing scientifically sound clinical trial evaluations.

“Over the years we have had the opportunity to establish true bonds with our clients,” said Quiring, Founder and Chief Science Officer. “They’ve found our work to be comprehensive and our interactions to be responsive, trustworthy, and respectful. In recent years, we’ve expanded our services beyond data and statistics to become a full service CRO. We simply outgrew our name.”

In September of 2018, QST named Phil Doren, PhD, as CEO. Under his direction the company solidified its comprehensive services offering and engaged Forma Life Science Marketing to guide them through the rebrand and name change.

“Working with Forma helped us find a path forward,” said Doren. “Forma reached out to every employee and several of our customers during their research and discovery phase. Those activities revealed one consistent piece of feedback that’s embodied by the time-tested saying, ‘our word is our bond.’

“Customer interviews revealed a deep level of trust and respect between us and our sponsors,” continued Doren. “With our new name — Abond — and our commitment to partnering with our customers, we reinforce what has become a hallmark of our work for the past 45 years — honesty, focus, and a willingness to assume responsibility.”

Abond’s website is being updated to reflect the new name, visual approach and to emphasize the company’s full-service CRO offerings. In addition, key Abond staff are attending S.C.O.P.E. in two weeks to publicly roll out the new brand and engage sponsors from across the country.

“We are extremely excited about updating our brand,” concluded Quiring. “We knew that it was time to clearly show how our focus has changed toward more service offerings, therapeutic areas, and technologies. When change like this comes to an organization you do not want to lose your character and what worked well. Abond tells our story in just one word.”

About Abond CRO Inc. (www.abondcro.com)

Abond is a full-service clinical research organization dedicated to providing specialized clinical research support for the pharmaceutical and medical device industries since its founding in 1974 (incorporation in 1985). They deliver everything you’d expect from a full-service CRO — consulting, clinical operations, data management, statistical analysis — and a few things that set them apart: honesty, focus, and responsibility. Abond works with small startup organizations to established pharmaceutical and medical device leaders around the world.

About Forma Life Sciences Marketing

Forma Life Science Marketing is a full-service agency that specializes in working with life science organizations, helping them build brand value, increase differentiation and boost sales and margins. Headquartered in Raleigh NC, the Forma team is comprised of seasoned professionals with expertise in strategy, brand alignment, marketing collateral, new media, and more.

Contacts

Abond CRO Inc.
Charley Bratton
919-316-8111
cbratton@abondcro.com

Abond CRO Inc.

Details
Headquarters: Allendale, MI
CEO: Phil Doren
Employees: 64
Organization: PRI

Release Versions

Contacts

Abond CRO Inc.
Charley Bratton
919-316-8111
cbratton@abondcro.com

More News From Abond CRO Inc.

ADDING MULTIMEDIA Danita Harris Joins Abond CRO as Executive Director, Clinical Data Management

ALLENDALE, Mich.--(BUSINESS WIRE)--Dr. Phil Doren, CEO and Vice President, is pleased to announce that Danita Harris has joined Abond CRO as Executive Director, Data Management. Ms. Harris brings 23 years of research experience, with most of that time in Data Management. Early in her career, Danita led individual studies and then moved up through to DM Leadership. Her expertise includes DM account management with small, mid, and large pharma companies, including establishing new working partner...

Abond CRO Announces That Mr. Zoran Antonijevic Is Their New Vice President, Statistical Consulting

ALLENDALE, Mich.--(BUSINESS WIRE)--Dr. Phil Doren, Chief Executive Officer and Vice President, is pleased to announce today that Zoran Antonijevic is the Vice President, Statistical Consulting at Abond CRO Inc. “With this single appointment, we have greatly strengthened our capability to address customers’ needs in statistical consulting for drug development,” Doren said. Mr. Antonijevic is an industry thought leader with cutting edge knowledge of innovative methods and strategies including ada...

Abond CRO Announces that Dr. Susan Walker is a Member of Board of Directors

ALLENDALE, Mich.--(BUSINESS WIRE)--Dr. Phil Doren, Chief Executive Officer, announced today that Dr. Susan Walker is a member of the Board of Directors of Abond CRO Inc. Dr. Walker is an independent consultant and the immediate past director of the Division of Dermatology and Dental Products (DDDP) at the US Food and Drug Administration (FDA). From 2006 to 2014 she led this division of over 40 senior physicians, scientists, and staff with responsibilities for review and approval of regulatory a...
Back to Newsroom